05 jan: DSV, 642 - Storaktionærmeddelelse
06 jan: Indre værdi af SmallCap Danmark A/S er opgjort til 84,4 kr. pr. ..
06-01-2017 07:58:46

Knud Vindfeldt steps down from the Executive Board of Chr. Hansen Holding A/S

Relateret indhold
17:04 - 
Onsdagens aktier: Beskedent fald til C20 efter stribe a..
03 aug - 
Aktier/middag: Et par C20'ere på rekordkurs i ellers sl..
02 aug - 
Aktier/middag: C20 løftes af rekorder i DSV og Chr. Han..
Relateret debat
05 jul - 
Du kan gå tilbage til første dag jeg var p..
05 jul - 
HAHA Så backtrader du igen
05 jul - 
Hvormeget af dagens kursstigning mon er eufori. Tror de..

Hoersholm, 2017-01-06 07:58 CET (GLOBE NEWSWIRE) --

 

Company announcement No. 01/2017

After more than 25 years with Chr. Hansen and 11 years in Executive Management, Knud Vindfeldt will step down from the Executive Board of Chr. Hansen Holding A/S on 28 February 2017.

Knud Vindfeldt joined Chr. Hansen in 1991 and was appointed member of the Executive Board of Chr. Hansen Holding A/S and head of the Cultures & Enzymes Division in 2005, and was further appointed COO and Deputy CEO in 2016. After February, Knud will continue to support Chr. Hansen in the role of advisor to the CEO for a period of six months.

Cees de Jong, CEO of Chr. Hansen, says: “Knud has been one of the key drivers behind the success of Chr. Hansen in the dairy market, and he has relentlessly pushed for continued improvements in our strategic, operational and financial performance. The results delivered by the Food Cultures & Enzymes Division (FC&E) speak for themselves; since 2005, both revenue and EBIT margin have more than doubled.

“With the transfer of the commercial responsibility for FC&E to Christoffer Lorenzen in April last year, the recent recruitment of Thomas Schäfer as Chief Scientific Officer and, today, with the promotion of Torsten Steenholt to Executive Vice President, Global Operations and member of the Corporate Leadership Team, we have ensured Knud’s succession. On behalf of the entire Chr. Hansen organization, I would like to thank Knud for his exceptional contribution to Chr. Hansen and wish him all the best for the future.”

Knud Vindfeldt says: “Chr. Hansen is a truly great company and it has been a fantastic journey, which I am proud to have been part of. The company is in better shape than ever, delivering solid results. With such strong successors in place, I feel confident that this is a natural time for me to step down. In the coming months, we will ensure a good handover.”

Following this change, the Executive Board will consist of CEO Cees de Jong and CFO Søren Westh Lonning. In addition, and as previously announced, Thomas Schäfer will join Chr. Hansen as CSO and member of the Executive Board in due course.

For further information, please contact:

Anders Mohr Christensen, Senior Director, Investor Relations

Tel.: +45 4574 7618

Camilla Lercke, Head of Media Relations

Tel.: +45 5339 2384

 

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2015/16 financial year was EUR 949 million. The company has more than 2,700 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen A/S. For further information, please visit www.chr-hansen.com.

 

Vedhæftet fil: No 01 2017 US.pdf

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Coloplast/CEO: Har underskrevet ny VA-kontrakt på trods af fejl

16-08-2017 14:33:48
En fejl i administrationen af kontrakten med det amerikanske veteranministerium, U.S Department of Veterans Affairs, har betydet, at det danske medicoselskab Coloplast vurderer, at det skal tilbagebetale 90 mio. kr. til ministeriet.Selskabets oplyste om engangsbeløbet i regnskabet for tredje kvartal af det forskudte regnskabsår 2016/2017, der blev fremlagt onsdag ved middagstid, og her fremgik det..

Aktier/middag: Mærsk og Carlsberg deles om top og bund i grønt C20

16-08-2017 11:33:01
Med plusser til størstedelen af de danske eliteaktier ligger C20 Cap-indekset onsdag middag i positivt terræn, og med til at trække op er Mærsk-aktierne efter koncernens regnskab. Omvendt bliver Carlsberg straffet for sit.Samlet går C20 Cap-indekset frem med 0,3 pct. til 1170,82, og dermed følger det danske eliteindeks trenden i resten af Europa, hvor de fleste aktieindeks ligeledes noterer stigni..

Aktier/tendens: Regnskaber i centrum for udvikling i C20 Cap

16-08-2017 08:36:09
Der er ikke meget påvirkning eller inspiration at hente fra udlandet for de danske investorer onsdag, og dagens udvikling i C20 Cap-indekset vil sandsynligvis blive bestemt af dagens regnskaber fra nogle af indekset tunge selskaber med A.P. Møller-Mærsk i spidsen.C20 Cap-indekset lukkede tirsdag med et fald på 0,1 pct. til 1167,07.De amerikanske aktier lukkede tirsdag med små udsving tæt på nulpun..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas/Sydbank: Sætter tungt aftryk på konkurrencepræget marked - NY
2
NNIT/CEO: Vi stopper ikke op og håber på Novo Nordisk
3
Spar Nord opjusterer og ændrer udbyttepolitik
4
Vestas bekræfter ordre på 424 MW i Mexico
5
Danske rederier har nået bunden - citat

Relaterede aktiekurser

Chr Hansen Holding A/S 517,50 1,5% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
16. august 2017 23:46:07
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170808.1 - EUROWEB4 - 2017-08-16 23:46:07 - 2017-08-16 23:46:07 - 1 - Website: OKAY